ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0228436 | null | Nuclei corporis trapezoidei|Medial nucleus of trapezoid body|Nuclei of trapezoid body|Set of nuclei of trapezoid body|Trapezoid body nucleus|Trapezoid body nucleus structure (body structure)|Nucleus medialis corporis trapezoidei|Trapezoid body nucleus structure | Trapezoid body nucleus |
C0205115 | null | Afferent (qualifier value)|Coming to|Afferent | Afferent |
C0206441 | Projection neurons in the CEREBRAL CORTEX and the HIPPOCAMPUS. Pyramidal cells have a pyramid-shaped soma with the apex and an apical dendrite pointed toward the pial surface and other dendrites and an axon emerging from the base. The axons may have local collaterals but also project outside their cortical region. | pyramidal cell|Pyramidal Cell|Neuron, Pyramidal|Cell, Pyramidal|Pyramidal Neurons|Pyramidal Neuron|Pyramidal cell (cell)|Cells, Pyramidal|Neurons, Pyramidal|Pyramidal cell|Pyramidal Cells | Pyramidal Cells |
C0033306 | Any natural or laboratory-made substance that has some or all of the biologic effects of progesterone, a female hormone. | Progestins|Gestagen|gestagens|Progestational Hormones|Progestational hormones|progestogen|Progestin|Gestagenic Agents|Progestagen|progestin|Progestagens|progestogens|PROGESTIN PREPARATIONS|progestational hormones|Progestogens|progestins|gestagen|progestagen|Progestational Agents|progestagens|Gestagens|Progestin preparation, NOS|PROGESTINS|Synthetic Progestagen|Progestogen|Progestogen preparation, NOS|Progestagenic Agents|Progestational Compounds|Progestational hormone|Progestational hormone (substance) | Progestins |
C0167626 | The synthetic benzoate ester of estradiol, a steroid sex hormone vital to the maintenance of fertility and secondary sexual characteristics in females. As the primary, most potent estrogen hormone produced by the ovaries, estradiol binds to and activates specific nuclear receptors. This agent exhibits mild anabolic and metabolic properties, and increases blood coagulability. (NCI04) | oestradiol benzoate|Estradiol benzoate (substance)|benzoato de estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol 3-Benzoate|estradiol 3 benzoate|Estradiol benzoate|oestradiol 3-benzoate|ESTRADIOL BENZOATE|estradiol benzoate|Estradiol Benzoate|estradiol 3-benzoate | estradiol 3-benzoate |
C0262200 | null | Periventricular Nucleus, Anteroventral|Anteroventral periventricular nucleus|Nucleus periventricularis anteroventralis|Nucleus, Anteroventral Periventricular | Anteroventral Periventricular Nucleus |
C0008996 | A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) | Clofaziminum|3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine|Clofazimin|Clofazimina|CLOFAZIMINE|2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-|2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-|Product containing clofazimine (medicinal product)|Clofazimine (substance)|N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine|Riminophenazine|Clofazimine|Clofazimine-containing product|clofazimine | clofazimine |
C0008996 | A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) | Clofaziminum|3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine|Clofazimin|Clofazimina|CLOFAZIMINE|2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-|2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-|Product containing clofazimine (medicinal product)|Clofazimine (substance)|N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine|Riminophenazine|Clofazimine|Clofazimine-containing product|clofazimine | clofazimine |
C0008996 | A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) | Clofaziminum|3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine|Clofazimin|Clofazimina|CLOFAZIMINE|2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-|2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-|Product containing clofazimine (medicinal product)|Clofazimine (substance)|N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine|Riminophenazine|Clofazimine|Clofazimine-containing product|clofazimine | clofazimine |
C1289555 | null | Entire medial preoptic nucleus|Entire medial preoptic nucleus (body structure) | Entire medial preoptic nucleus |
C0998704 | A species of SEA URCHINS in the family Strongylocentrotidae found on the Pacific coastline from Alaska to Mexico. This species serves as a major research model for molecular developmental biology and other fields. | purple urchin|Sea Urchins, Purple|Strongylocentrotus purpuratus|Urchin, Purple Sea|Purple Sea Urchin|Sea Urchin, Purple|Urchins, Purple Sea|Purple Sea Urchins | Strongylocentrotus purpuratus |
C0027757 | Differentiated tissue of the central nervous system composed of NERVE CELLS, fibers, DENDRITES, and specialized supporting cells. | Tissue, Nervous|Nervous Tissues|nervous tissue|NEURONS, TRACTS AND FIBERS|Tissues, Nerve|nervous tissues|Structure of nervous tissue (body structure)|Nerve Tissue|Nerve tissue|Nerve Tissues|Neural tissue, NOS|Nervous tissue|nerves tissue|Textus nervosus|Nervous Tissue|Portion of neural tissue|neural tissue|Neurons, Nerve Tracts and Nerve Fibers|Tissues, Nervous|nerve tissue|neural tissues|Structure of nervous tissue|Neural tissue|Tissue, Nerve|Human Nerve Tissue|nerve tissues | Nerve Tissue |
C0206513 | A cylinder-shaped mechanoreceptor cell that detects and transduces head movements into neural impulses amd is located within the vestibular and auditory systems of all vertebrates. | Outer Hair Cells|Type II hair cell|outer hair cells|Type II Hair Cells|Type 2 vestibular hair cell|Type 2 vestibular sensory cell|cells hair outer|Type II hair cell (cell)|Outer Hair Cell|Type II Hair Cell | Type 2 vestibular sensory cell |
C0018496 | Sensory cells in the organ of Corti, characterized by their apical stereocilia (hair-like projections). The inner and outer hair cells, as defined by their proximity to the core of spongy bone (the modiolus), change morphologically along the COCHLEA. Towards the cochlear apex, the length of hair cell bodies and their apical STEREOCILIA increase, allowing differential responses to various frequencies of sound. | auditory receptor|Auditory Hair Cells|Cochlear Hair Cell|Hair cell (cell)|hair cells|Ear Hair Cell|Hair Cell, Cochlear|Auditory Hair Cell|Hair Cells, Auditory|hair cell|Hair Cell|Cells, Cochlear Hair|Hair cell|auditory hair cell|Corti cell|Cochlear hair cell|Cell, Cochlear Hair|ear hair cell|Auditory receptor|Hair cells|Corti Cell|Cochlear Hair Cells|Hair Cells|cell hair|Hair cell, NOS|Hair Cells, Cochlear|Hair Cell, Auditory | Auditory Hair Cell |
C0544533 | null | Flavoprotein enzyme (substance)|Flavoenzyme|Flavoprotein enzyme | Flavoprotein enzyme |
C0010895 | null | D Amino Acid Dehydrogenase|D-Amino Acid Dehydrogenase|D-Amino-acid oxidase|D Amino Acid Oxidase|Oxidase, D-Amino-Acid|Dehydrogenase, D-Amino Acid|D-amino-acid oxidase|dextro-Amino Acid Oxidase|D-Amino-acid:oxygen oxidoreductase (deaminating)|D-Amino-Acid Oxidase|Acid Oxidase, dextro-Amino|D-amino-acid oxidase (substance)|dextro Amino Acid Oxidase|Acid Dehydrogenase, D-Amino|Oxidase, dextro-Amino Acid | D-Amino Acid Dehydrogenase |
C0037114 | A broad family of synthetic organosiloxane polymers containing a repeating silicon-oxygen backbone with organic side groups attached via carbon-silicon bonds. Depending on their structure, they are classified as liquids, gels, and elastomers. (From Merck Index, 12th ed) | Silicones|Silicone|SILICONE|Product containing silicone (medicinal product)|silicones|Silicone-containing product|Silicone (substance)|silicone | silicones |
C0037114 | A broad family of synthetic organosiloxane polymers containing a repeating silicon-oxygen backbone with organic side groups attached via carbon-silicon bonds. Depending on their structure, they are classified as liquids, gels, and elastomers. (From Merck Index, 12th ed) | Silicones|Silicone|SILICONE|Product containing silicone (medicinal product)|silicones|Silicone-containing product|Silicone (substance)|silicone | silicones |
C0011305 | Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS. | Dendrite (cell structure)|Dendrites|Dendrite|dendrites|dendrite|Dendritic | Dendrites |
C1564137 | A family of vesicular neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters. Vesicular glutamate transport proteins sequester the excitatory neurotransmitter GLUTAMATE from the CYTOPLASM into SECRETORY VESICLES in exchange for lumenal PROTONS. | Transporters, Vesicular Glutamate|Transport Proteins, VGLUT|Vesicular Glutamate Transporter Proteins|Vesicular Glutamate Transporters|VGLUT Transport Proteins|Glutamate Transporters, Vesicular | Vesicular Glutamate Transport Proteins |
C0006463 | An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. | 1,4-bis(methanesulfonoxy)butane|bsf|busulphan|1,4-Bis(methanesulfonoxy)butane|1,4-Dimethanesulfonoxybutane|Bussulfam|1,4-Butanediol, dimethanesulfonate|1,4-Di(methylsulfonyloxy)butane|tetramethylene bis(methanesulfonate)|Tetramethylene Bis(methanesulfonate)|1,4-Di(methanesulfonyloxy)butane|1,4-Dimesyloxybutane|1,4-Butanediol dimethanesulfonate|Busulphan|1,4-di(methylsulfonyloxy)butane|1,4-Bitanediol Dimethanesulfonate Esters|1,4-bitanediol dimethanesulfonate esters|Methanesulfonic Acid Tetramethylene Ester|Product containing busulfan (medicinal product)|1, 4-Bis[methanesulfonoxy]butane|busulfan|1,4-di(methanesulfonyloxy)butane|Tetramethylene bis[methanesulfonate]|Tetramethylene bis(methanesulfonate)|1,4-Butanediol Dimethylsulfonate|Methanesulfonic acid, tetramethylene ester|Busulfan|BSF|BU|BUSULFAN|1,4-butanediol dimethylsulfonate|Busulfan-containing product|methanesulfonic acid, tetramethylene ester|BUS|Busulfanum|Busulfano|Sulfabutin|Myeleukon|Busulfan (substance) | busulfan |
C0023686 | Fibrous cords of CONNECTIVE TISSUE that attach bones to each other and hold together the many types of joints in the body. Articular ligaments are strong, elastic, and allow movement in only specific directions, depending on the individual joint. | joint ligament|Ligament, Articular|articular ligament|Articular Ligament|Articular Ligaments|Ligaments, Articular|joints ligaments|joint ligaments|Structure of ligament of joint (body structure)|Structure of ligament of joint|Ligament of joint | Articular ligaments |
C0026004 | A toxicology screening result where proliferating cells that are exposed to a genotoxic chemical produce some daughter cells containing cytoplasmic bodies that are comprised of chromosomes or chromosome fragments, which were not sorted properly during mitosis or meiosis, and are bounded by a nuclear membrane. | Micronucleus|Micronuclei|Micronucleus (morphologic abnormality)|micronuclei|micronucleus | Micronucleus - abnormality |
C0229471 | null | Outer phalangeal cell of cochlea|Deiter cell|External phalangeal cell of Deiters|sustentacular cell|External phalangeal cell of cochlea|Chalice cell|Deiter's cell (cell)|Deiter's cell|External phalangeal cell|Supporting cell of Deiters|Phalangeal cell of cochlea|Sustentacular cell | Phalangeal cell of cochlea |
C0440426 | null | Rat epithelium (substance)|Rat epithelium | Rat epithelium |
C0599332 | An epithelium located in the roof, superior conchae, and septum of the nasal cavity. It is formed by ciliated olfactory receptor cells, supporting cells and basal cells. Olfactory glands in the epithelium produce and secrete mucus which forms a layer over the epithelium. The cilia of the receptor cells protrude into the mucous layer where molecular reception with odors occurs and sensory transduction begins. | Epithelium, Olfactory|olfactory epithelium|Olfactory epithelium|Olfactory sensory epithelium|epithelium olfactory|Sensory olfactory epithelium|Olfactory Epithelium|Olfactory sensory epithelium (body structure) | Olfactory Epithelium |
C1373111 | null | Nucleoside Reverse Transcriptase Inhibitors [MoA] | Nucleoside Reverse Transcriptase Inhibitors |
C0667846 | null | Combivir|combivir | Combivir |
C0667846 | null | Combivir|combivir | Combivir |
C0014699 | A series of structurally-related alkaloids that contain the ergoline backbone structure. | ergoline|Ergolines|ergolines | Ergolines |
C0065356 | null | Lysergic acid amide (substance)|lysergic acid amide|Lysergic acid amide|9,10-didehydro-6-methylergoline-8 beta-carboxamide | lysergamide |
C0021236 | bicyclic nitrogenous heterocyclic compounds. | indole|INDOLE|Indole, 3-Benzopyrrole, 1-benzazole|Indole|Indole (substance) | indole |
C0369632 | null | Acid, Lysergic|Ergoline-8-carboxylic acid, 9,10-didehydro-6-methyl-, (8beta)-|Lysergic Acid|lysergic acid | Lysergic Acid |
C0014707 | Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists. | Alkaloids, Ergot|Alkaloids, Clavine|Ergot alkaloids|ergot alkaloid|ergot alkaloids|Ergot alkaloid|Ergot alkaloid, NOS|Ergot Alkaloids|Ergot alkaloid-containing product|Product containing ergot alkaloid (product)|Ergot alkaloid (substance)|Clavine Alkaloids|alkaloids ergot | ergot alkaloids |
C0034830 | One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. | Receptors, Nicotinic|Nicotinic acetylcholine receptor|receptor nicotinic|Nicotinic receptors|Nicotinic Acetylcholine Receptor|Nicotinic Acetylcholine Receptors|Acetylcholine Receptors, Nicotinic|acetylcholine nicotinic receptor|Nicotinic Receptor|Receptor, Nicotinic|Nicotinic receptor|Acetylcholine Receptor, Nicotinic|Nicotinic receptor (substance)|nicotinic receptors|Receptor, Nicotinic Acetylcholine|nicotinic receptor|Nicotinic receptor site|Receptors, Nicotinic Acetylcholine|Nicotinic Receptors | Nicotinic Receptors |
C0030095 | A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. | OXYTOCIN|Oxytocin-containing product|Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, cyclic 1-6 disulfide|oxytocin|Oxytocin (substance)|Oxytocin preparation|Product containing oxytocin (medicinal product)|Oxytocin|ocytocin|Ocytocin|Oxitocina | oxytocin |
C0043328 | A xanthophyll found in the major LIGHT-HARVESTING PROTEIN COMPLEXES of plants. Dietary lutein accumulates in the MACULA LUTEA. | (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol|Luteine|All-Trans-Lutein|Lutein|Lutein, gamma|gamma Lutein|lutein|Lutein (substance)|Leutin|Adaptinol|beta,epsilon-Carotene-3,3'-diol, (3R,3'R,6'R)-|LUTEIN|4-[18-(4-hydroxy-2,6,6-trimethyl-1-cyclohex-2-enyl)-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-cyclohex-3-en-1-ol|LUT|Xanthophyll | lutein |
C0013123 | A measurement of a subject's water intake. | Water Consumption|Water intake (observable entity)|Water intake|WC|Water Intake|H2O - Water intake | Water consumption |
C0872076 | Cells that can give rise to cells of the three different GERM LAYERS. | Pluripotent Stem Cell|pluripotent stem cell|Pluripotent stem cell|pluripotent stem cells|Pluripotential stem cell|Stem Cells, Pluripotent|Pluripotent Stem Cells|Stem Cell, Pluripotent | Pluripotent Stem Cells |
C0018757 | The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. (From Last, Dictionary of Epidemiology, 2d ed) | Health Research Service|HEALTH SERVICES RESEARCH|Evaluation, Health Services|Research, Health Services|hsr|healthcare research|research healthcare|Evaluations, Health Services|Research, Medical Care|HSR|health research services|Health Care Research|Health Services Evaluations|care health research|Medical Care Research|Health Services Research|Healthcare Research|Health Services Evaluation|health care research|health services research|Research, Healthcare|medical care research|Medical care--Research|Research, Health Care | Health Services Research |
C0238884 | null | canadian|Canadian (ethnic group)|CANADIAN | Canadian |
C0017887 | A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. | Glyceroltrinitrat|Glyceryl trinitrate (substance)|Glyceryl Trinitrate|Product containing glyceryl trinitrate (medicinal product)|Glycerin trinitrate|1,2,3-propanetrioltrinitrate|Trinitroglycerol|Glycerol, nitric acid triester|Glyceryl trinitrate-containing product|glyceryl trinitrate|nitroglycerol|1,2,3-Propanetriol, trinitrate|Propane-1,2,3-triyl trinitrate|Nitroglycerin|Glyceroli trinitratis|NITROGLYCERIN|Glycerol trinitrate|nitroglycerin|nitroglycerine|Nitroglycerine|Trinitrate, Glyceryl|NG|1,2,3-propanetriyl nitrate|Nitroglycerin-containing product|Trinitrine|Glyceryl trinitrate|Trinitroglycerin|Nitroglicerina|1,2,3-propanetriol trinitrate|Nitroglycerol | nitroglycerin |
C0042200 | The administration of live or attenuated influenza virus for the prophylaxis of influenza. | Influenza vaccination (procedure)|influenza immunization|flu immunization|flu vaccination|Immunization, influenza|Influenza immunisation|immunization influenza|flu immunisation|vaccination flu|vaccination influenza|Prophylactic vaccination against influenza|flu vaccinations|influenza vaccination|flu prevention|Influenza vaccination|Influenza Vaccination|immunizations influenza|Influenza immunization|influenza vaccinations | Influenza vaccination |
C0105185 | null | null | BANS |
C0871010 | null | opinion|opinions|Opinion | Opinions |
C0009237 | A beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated. | coffea|Coffee (substance)|Coffee|Coffee, NOS|coffee | Coffee |
C0907648 | An eph family receptor found primarily in the nervous system. In the embryonic BRAIN EphB1 receptor expression occurs in the mantle layer and increases with the progression of embryogenesis. In adult brain it is found in the several regions including the CEREBELLUM; CEREBRAL CORTEX; and CAUDATE NUCLEUS; and PUTAMEN. | Neuronally Expressed EPH Related Tyrosine Kinase|EphB1 Receptor|Receptor, EphB1|Neuronally Expressed EPH-Related Tyrosine Kinase|EPHT2 Protein | Ephrin Receptor EphB1 |
C0038998 | Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) | Agents, Sweetening|Sweeteners|sweetening agent|Agent, Sweetening|Sweetener|sweetener|sweeteners|Sweetening Agents|Sweetening Agent|sweetening agents | Sweetening Agents |
C0027778 | Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. | holland|NETHERLANDS|The Netherlands|netherlands|NL|Netherlands|Netherlands (geographic location)|netherland|Holland|Kingdom of the Netherlands|NLD | Netherlands |
C0032989 | The condition of carrying two or more FETUSES simultaneously. | PREGNANCY MULTIPLE|Unspecified multiple gestation|Unspecified multiple gestation, unspecified as to episode of care or not applicable|multiples pregnancy|Pregnancies, Multiple|MULTIPLE PREGNANCY|Multiple Gestation|Multiple gestation, NOS|multiple gestation|multiple pregnancy|Multiple Pregnancies|multiple pregnancies|Pregnancy, Multiple|Multiple Pregnancy|Multiple pregnancy, NOS|Multiple pregnancy (disorder)|Multiple gestation|Unspecified multiple gestation, unspecified as to episode of care|gestation multiple|gestations multiple|Multiple pregnancy|pregnancy multiple|Pregnancy, multiple | Multiple Pregnancy |
C0474232 | null | b hepatitis vaccinations|b hepatitis immunization|b hepatitis injections|Hepatitis B immunization|Hepatitis B series immunization|hepatitis b vaccination|b hepatitis immunizations|vaccination hepatitis b|Hepatitis B injection|Hepatitis B series immunisation|Administration of hepatitis b vaccine|hep b vaccination|Hepatitis B vaccination|Hep B vaccination|Hepatitis B vaccination (procedure)|hepatitis b immunization|b hepatitis vaccination|hepatitis b immunisation|Hepatitis B immunisation|b hep vaccination|immunisation hepatitis b | Hepatitis B vaccination |
C0149709 | An indication that the hepatitis B virus surface protein antigen has been detected in a sample. | Hepatitis B Surface Protein Antigen Positive|HAPATITIS B SURFACE ANTIGEN POSTIVE|Hepatitis B surface antigen positive (finding)|Hepatitis B Surface Antigen Positive|HEPATITIS B POSITIVE SA|HEPATITIS B SURFACE ANTIGEN POSITIVE|HAA POSITIVE|HBs Antigen Positive|HBsAg Positive|HBsAg positive|HBSAG POSITIVE|HBs Positive|Hepatitis B Virus Surface Antigen Positive | Hepatitis B surface antigen positive |
C0419726 | null | First hepatitis B vaccination (procedure)|1st hepatitis B vaccination | First hepatitis B vaccination |
C0814362 | null | indicated preventive measure|indicated preventive interventions|individually indicated prevention|prevention directed at individuals | indicated prevention |
C0019559 | A sensation of discomfort emanating from the pelvis, its supporting structures, or its articulation with the femur (acetabulofemoral or femoroacetabular joint). | hip joint pains|Hip pain (finding)|Hip Pain|Hip joint pain|hip pains|hips pain|Arthralgia (hip)|hip arthralgia|painful hip|Hip arthralgia|Coxalgia|hip joint pain|coxalgia|Arthralgia of the hip|Hip painful|Arthralgia of hip|hip pain|Hip pain|hip joints pain|pain in hip | Hip joint pain |
C1279103 | null | Entire anterior inferior iliac spine (body structure)|Entire anterior inferior iliac spine | Entire anterior inferior iliac spine |
C0262386 | null | avulsion|Avulsed wound|avulsions|Avulsion|Avulsed|Avulsion - injury (disorder)|avulsion injuries|avulsed|Avulsion - injury|avulsion injury|avulsed wound|AVULSION|Avulsion (morphologic abnormality)|Wound, avulsed | Avulsed wound |
C0150005 | null | viral myositis|VIRAL MYOSITIS|myositis viral|Viral myositis (disorder) | Viral myositis |
C0238883 | null | null | CALF TENDERNESS |
C0865850 | null | null | Acute respiratory insufficiency |
C0189386 | null | Endoscopy of trachea (procedure)|Tracheoscopy, NOS|Tracheoscopy|Endoscopy of trachea, NOS | Endoscopy of trachea |
C0040584 | INFLAMMATION of the TRACHEA that is usually associated with RESPIRATORY TRACT INFECTIONS. | Tracheitis (disorder)|Tracheitis|Tracheal Inflammation|tracheitis|Tracheitides|TRACHEITIS|Tracheitis, NOS|Inflamed trachea | Tracheitis |
C0398353 | Respiratory failure due to a high level of carbon dioxide in the blood. | hypercapnic respiratory failure|Hypercapnic respiratory failure (disorder)|failure hypercapnic respiratory|Type 2 respiratory failure|Type II respiratory failure|type 2 respiratory failure|Hypercapnic respiratory failure|ventilatory failure | Hypercapnic respiratory failure |
C0038769 | Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2. | sulfotransferase|Sulfotransferase|Sulfotransferase (substance)|EC 2.8.2|Sulfotransferases|Sulphotransferase | sulfotransferase |
C0038717 | null | Sulfatase (substance)|sulphatase|Sulfatase|Sulfatases|6-sulfatase|Sulfuric ester hydrolase|sulfatase|6-Sulfatase|sulfatases|Arylsulfatase|sulfuric ester hydrolase|Sulphatases|arylsulfatase | Sulfatases |
C0042460 | The inferior and superior venae cavae. | VENA CAVA|Cavae, Venae|Venae cavae|Vena caval|Venae Cavae|Vena Cava|Vena caval structure (body structure)|Vena cava, NOS|vena caval|cava vena|Vena caval structure|Vena cava|vena cava|VEIN, VENA CAVA | Vena cava structure |
C0018183 | Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. | Polymorphonuclear leucocyte|Granulocytic cell (cell)|Polymorphonuclear leukocyte|Granulocytic cell|granulocytes|Granulocytic Cell|Granular Leukocyte|Granular Leukocytes|granulocyte|cells granulocyte|granular leukocyte|Granulocyte|Blood granulocytic cell|Granulocytic|Granulocytic cell, NOS|Granulocytes|Granular leucocyte|Granular leukocyte | granulocyte |
C0027229 | A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. | Formylmethionylleucylphenylalanine|N-Formylmethionine Leucyl-Phenylalanine|N Formyl Methionyl Leucyl Phenylalanine|Formylmet-Leu-Phe|fMLP (formyl-met-leu-phe)|Formylmethionyl-Leucyl-Phenylalanine|L-Phenylalanine, N-(N-(N-formyl-L-methionyl)-L-leucyl)-|N Formylmethionine Leucyl Phenylalanine|Formylmet Leu Phe|N-Formyl-Methionyl-Leucyl-Phenylalanine|Formylmethionyl Leucyl Phenylalanine|Leucyl-Phenylalanine, N-Formylmethionine | N-Formylmethionine Leucyl-Phenylalanine |
C0162518 | Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions (e.g., growth, lysis). | Medium, Conditioned|Conditioned Culture Media|Media, Conditioned|Conditioned Media|Conditioned Medium|Conditioned Culture Medium|Culture Medium, Conditioned | Culture Media, Conditioned |
C0060291 | null | 4-hydroxy-3-methoxycinnamic acid|2-propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-|ferulic acid|Ferulic Acid|FERULIC ACID | ferulic acid |
C1304890 | An intended site for a dose form that is for administration to the gastrointestinal tract. | Enteric|Enteral (intended site)|Enteral (qualifier value)|enteric|enteral|Enteral | Enteral |
C0440471 | null | Materials, Genetic|Genetic material (substance)|Genetic Material|Material, Genetic|Genetic material|genetic material | Genetic Materials |
C0058347 | Molecular oxygen, O2, having two unpaired electrons in its most stable form. | Dioxygen|dioxygen | Dioxygen |
C0001652 | Pigment obtained by the oxidation of epinephrine. | 1H-Indole-5,6-dione, 2,3-dihydro-3-hydroxy-1-methyl-|Adrenochrome|Adrenochrome (substance) | Adrenochrome |
C0011947 | Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material. | DIALYSIS FLUID|dialysis solution|Solutions, Dialysis|dialysis solutions|Dialysis fluid (product)|dialysate|Dialyzates|Dialysis fluid (substance)|Dialysis fluid|Dialysates|dialysis fluids|Dialysis Solutions|Dialysis Fluid|Dialysate | Dialysis Solutions |
C0442034 | Having to do with the peritoneum (the tissue that lines the abdominal wall and covers most of the organs in the abdomen). | Peritoneal|Peritoneal (qualifier value)|peritoneal | peritoneal |
C0225335 | A flat cell of mesenchymal origin that forms the superficial layer of the serosal membranes lining the body cavities of the abdomen and thorax. | Mesothelial cell|Mesotheliocyte|Mesothelial Cell|mesothelial cells|mesothelial cell|cells mesothelial|Mesothelial cell (cell) | Mesothelial cell |
C0019065 | Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE. | Peritoneal hemorrhage, NOS|bleeds peritoneal|Haemoperitoneum|abdominal apoplexy|HEMOPERITONEUM|Hemoperitoneum|Intraperitoneal hemorrhage|Peritoneal haemorrhage|Peritoneal haemorrhage, NOS|Peritoneal hemorrhage|Intraabdominal hemorrhage|hemoperitoneum|PERITONEAL HEMORRHAGE|Hemoperitoneums|haemoperitoneum|peritoneal bleeding|peritoneal hemorrhage|intraperitoneal hemorrhage|Peritoneal Hemorrhage|peritoneal bleed|HAEMOPERITONEUM|PERITONEAL BLEEDING|HEMORRHAGE PERITONEAL|APOPLEXY, ABDOMINAL|HEMORRHAGE INTRAPERITONEAL|Hemoabdomen|Hemoperitoneum, NOS|MESENTERY, HEMORRHAGE|Hemorrhage into peritoneal cavity (disorder)|Haemorrhage into peritoneal cavity|Abdominal apoplexy|Intraperitoneal haemorrhage|Hemorrhage into peritoneal cavity|PERITONEAL EFFUSION BLOODY | Hemoperitoneum |
C0031154 | INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. | Unspecified peritonitis|Peritonitis, NOS|Inflammation of the peritoneum|Peritonitis NOS|peritonitis|Peritonitis|Peritoneal inflammation|PERITONITIS|Peritonitis of unspecified cause|Peritonitis (disorder)|Peritonitis of undetermined cause | Peritonitis |
C0027581 | class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures; many species are parasites. | Roundworm, NOS|Nematode|nematode|roundworm <Nematoda>|Roundworms|Phylum Nemata|roundworms|Nema|roundworm|Roundworm|nematodes|Nematode, NOS|Nematoda|Threadworms|nematoda|PHYLUM NEMATODA|Threadworm|Nemata|Phylum Nemata (organism)|Phylum Nematoda | Phylum Nematoda |
C0016536 | Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST. | Forearm structure|Forearm, NOS|Forearms|Intermediate segment of free upper limb|forearm|Antebrachium|Set of forearm|Pair of forearm|forearms|Forearm|Antebrachiums|Antebrachial region|Forearm structure (body structure)|FOREARM|Regio antebrachialis | Forearm |
C0043272 | A white threadlike worm which causes elephantiasis, lymphangitis, and chyluria by interfering with the lymphatic circulation. The microfilaria are found in the circulating blood and are carried by mosquitoes. | Bancrofti filaria|Filaria bancrofti|Wuchereria bancrofti (organism)|Wuchereria bancrofti|Filaria sanguinis hominis|WUCHERERIA BANCROFTI|wuchereria bancrofti|bancrofti wuchereria | Filaria bancrofti |
C1137094 | Personal behaviors designed to minimize and control the probability and/or impact of unfortunate events. | reduction risks|Risk Reduction|reductions risk|risk reduction | Risk Reduction |
C0262500 | null | routine health care maintenance|hm|hms|rhcm|hcm|routine health maintenance|rhm|routine healthcare maintenance|health care maintenance|health maintainence|health maintenance|HEALTH MAINTENANCE|healthcare maintenance | Health maintenance |
C0180407 | null | dialysis unit|dialysis units | Dialysis units (machines) |
C0025854 | A quinazoline-sulfonamide derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS. | 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide|Metolazone (substance)|Metolazonum|Metolazone-containing product|Metolazona|7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide|6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-|2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone|Product containing metolazone (medicinal product)|Métolazone|Metolazone|Metolazene|Metolazon|METOLAZONE|metolazone | metolazone |
C0489749 | null | rectal temperatures|temperature rectal|Core body temperature measured in rectum (observable entity)|Core body temperature measured in rectum|Rectal temperature|rectal temperature | Rectal temperature |
C0003450 | Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS. | Antivenom|Animal antiserum, NOS|Antivenom-containing product|Antivenoms|Animal immune serum, NOS|Anti-Venins|Antivenin|Antivenin, NOS|Antivenins|antivenins|antivenin|Anti Venoms|Anti-Venoms|antivenom|ANIMAL ANTISERUMS|antivenoms|Product containing antivenom (product)|Antivenom (substance)|Anti Venins | Antivenin |
C0003450 | Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS. | Antivenom|Animal antiserum, NOS|Antivenom-containing product|Antivenoms|Animal immune serum, NOS|Anti-Venins|Antivenin|Antivenin, NOS|Antivenins|antivenins|antivenin|Anti Venoms|Anti-Venoms|antivenom|ANIMAL ANTISERUMS|antivenoms|Product containing antivenom (product)|Antivenom (substance)|Anti Venins | Antivenin |
C0085684 | null | foot-drop|footdrop|FD - Foot-drop|Foot Drop|foot drop|Foot Drops|Dropfoot|dropfoot|Footdrop|FOOTDROP|drop foot|dropping foot|Foot-drop (finding)|FOOT DROP|dropped foot|Foot drop|Foot-drop | Foot Drop |
C0600118 | null | talk|talks | Does talk |
C0013778 | An electrical current applied to the HEART to terminate a CARDIAC ARRHYTHMIA. | CARDIOVERSION, ELECTRICAL|Electric countershock|electric countershock|Electric Countershocks|Defibrillation|Cardioversions|Electrical Cardioversion|Electric Countershock|Countershock, Electric|Cardioverter Procedure|Cardioversions, Electrical|Electroversions, Cardiac|Electrical cardioversion|cardioversions|Conversion of cardiac rhythm|Electric Defibrillations|electric countershock heart resuscitation|Electrical Cardioversions|Cardioversion (procedure)|Conversion of cardiac rhythm, NOS|Defibrillations, Electric|Cardiac Electroversions|Cardioversion, Electrical|cardioversion|Electric Defibrillation|Cardiac countershock, NOS|ELECTRICAL CARDIOVERSION|cardiac electroversion|Electric Cardioversion|Cardioversion|defibrillation|Electroversion, Cardiac|Defibrillation, Electric|Countershocks, Electric|Cardiac Electroversion|Cardioversion, NOS | Electric Countershock |
C0180307 | Cardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia (TACHYCARDIA, VENTRICULAR) that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias (called synchronized defibrillation or CARDIOVERSION), using relatively low-level discharges synchronized to the patient's ECG waveform. (UMDNS, 2003) | cardioverter|Cardioverter, NOS|Cardioverter|Defibrillator, device (physical object)|Stimulators, Electrical, Cardiac, Shock|Defibrillator, NOS|Electric Shock Cardiac Stimulators|FIBRILLATOR, AC|Defibrillator|Defibrillators|defibrillators|defibrillator|Defibrillator, device | Defibrillators |
C0007203 | The artificial substitution of heart and lung action as indicated for HEART ARREST resulting from electric shock, DROWNING, respiratory arrest, or other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation (RESPIRATION, ARTIFICIAL) and closed-chest CARDIAC MASSAGE. | Cardiopulmonary resuscitation|cardiopulmonary resuscitation (CPR)|Resuscitation, Cardiopulmonary|CPR (cardiopulmonary resuscitation)|CPR - Cardiopulmonary resuscitation|Cardiopulmonary resuscitation (procedure)|cardio-pulmonary resuscitation|cardiopulmonary resuscitation|Cardiopulmonary resuscitation, NOS|Resuscitation, Cardio-Pulmonary|CPR|Cardio Pulmonary Resuscitation|Cardiopulmonary resuscitation, NOS (e.g. cardiac arrest)|Cardio-Pulmonary Resuscitation|heart resuscitation|Cardiopulmonary resuscitation, not otherwise specified|Cardiopulmonary Resuscitation | Cardiopulmonary Resuscitation |
C0004057 | The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) | Acide acétylsalicylique|Acid, Acetylsalicylic|2-Acetoxybenzoic acid|O-acetylsalicylic acid|2-(Acetyloxy)benzoic Acid|aspirin chemicals|Salicylic acid acetate|Product containing aspirin (medicinal product)|2-(acetyloxy)benzoic Acid|ácido acetilsalicílico|2-Acetoxybenzenecarboxylic acid|Acidum acetylsalicylicum|Acetylsalicylsäure|Acetylsalicylic Acid|Aspirin-containing product|Acetylsalicylic acid|Benzoic acid, 2-(acetyloxy)-|acide 2-(acétyloxy)benzoque|aspirin antiplatelet|Aspirina|acetylsalicylic acid|o-carboxyphenyl acetate|aspirin products|Aspirin (substance)|aspirins|Aspirin|ASA|aspirin|o-acetoxybenzoic acid|antiplatelet aspirin|Azetylsalizylsäure|ASPIRIN | aspirin |
C0239998 | Increased susceptibility to infections. [HPO:probinson, HPO:skoehler] | Frequent, severe infections|recurrent infection|INFECTION, RECURRENT|Recurrent infections|Predisposition to infections|Recurrent infectious disease (disorder)|Recurrent infectious disease|infection recurrent|Recurrent infection|Increased frequency of infection|Frequent infections|infections recurrent|infections, recurrent | Recurrent infections |
C0149778 | Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. (From Cecil Textbook of Medicine, 19th ed, p1688) | Soft tissue infection|infection soft tissue|soft tissue infection|Soft Tissue Infections|infections soft tissue|Soft tissue infection (disorder)|infections soft tissues|Soft tissue infection, NOS|SOFT TISSUE INFECTION|Soft Tissue Infection|soft tissue infections|Infection, Soft Tissue|Infections, Soft Tissue | Soft Tissue Infection |
C0982327 | null | peginterferons|peginterferon | PEGINTERFERON |
C0982327 | null | peginterferons|peginterferon | PEGINTERFERON |
C0020546 | A severe, acute increase in blood pressure that may result in stroke or myocardial ischemia. | Hypertensive crisis|Hypertensive Crisis|crisis hypertensive|CRISIS HYPERTENSIVE|Hypertensive crisis (disorder)|hypertensive crisis | Hypertensive crisis |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.